KEGG   DRUG: Rilpivirine hydrochloride - tenofovir disoproxil fumarate - emtricitabine mixtHelp
Entry
D10571            Mixture   Drug                                   

Name
Rilpivirine hydrochloride - tenofovir disoproxil fumarate - emtricitabine mixt;
Complera (TN);
Eviplera (TN)
Product
Component
Rilpivirine hydrochloride [DR:D09958], Tenofovir disoproxil fumarate [DR:D01982], Emtricitabine [DR:D01199]
Remark
Therapeutic category: 
ATC code: 
Activity
Antiviral
  Disease
HIV-1 infection [DS:H01563]
Interaction
Drug interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J05 ANTIVIRALS FOR SYSTEMIC USE
   J05A DIRECT ACTING ANTIVIRALS
    J05AR Antivirals for treatment of HIV infections, combinations
     J05AR08 Emtricitabine, tenofovir disoproxil and rilpivirine
      D10571  Rilpivirine hydrochloride - tenofovir disoproxil fumarate - emtricitabine mixt
Therapeutic category of drugs in Japan [BR:br08301]
 6  Agents against pathologic organisms and parasites
  62  Chemotherapeutics
   625  Antivirals
    6250  Antivirals
     D10571  Rilpivirine hydrochloride - tenofovir disoproxil fumarate - emtricitabine mixt
Antivirals [br08351.html]
 D10571
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D10571
BRITE hierarchy
Other DBs
PubChem: 
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system